These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32548871)

  • 41. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial.
    Sharp LK; Tilton JJ; Touchette DR; Xia Y; Mihailescu D; Berbaum ML; Gerber BS
    Pharmacotherapy; 2018 Jan; 38(1):58-68. PubMed ID: 29121408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control.
    Molló À; Berenguera A; Rubinat E; Vlacho B; Mata M; Franch J; Bolíbar B; Mauricio D
    BMC Fam Pract; 2019 Feb; 20(1):25. PubMed ID: 30732583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control.
    Fu AZ; Sheehan JJ
    Curr Med Res Opin; 2017 May; 33(5):853-858. PubMed ID: 28166431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study.
    Wan KS; Moy FM; Mohd Yusof K; Mustapha FI; Mohd Ali Z; Hairi NN
    PLoS One; 2020; 15(10):e0240531. PubMed ID: 33035261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
    Twigg G; Motsko J; Thomas J; David T
    Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
    Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
    Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes in an Interdisciplinary Diabetes Clinic in Rural Primary Care.
    King DE; Petrone AB; Alcantara FM; Elavsky MM; Prestoza MO; Siebart J; Castelli G
    South Med J; 2019 Apr; 112(4):205-209. PubMed ID: 30943537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal trends in intensification of glucose-lowering therapy for type 2 diabetes in Italy: Data from the AMD Annals initiative and their impact on clinical inertia.
    Cucinotta D; Nicolucci A; Giandalia A; Lucisano G; Manicardi V; Mannino D; Rossi MC; Russo GT; Di Bartolo P
    Diabetes Res Clin Pract; 2021 Nov; 181():109096. PubMed ID: 34673085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial.
    Choe HM; Mitrovich S; Dubay D; Hayward RA; Krein SL; Vijan S
    Am J Manag Care; 2005 Apr; 11(4):253-60. PubMed ID: 15839185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting.
    Kallenbach L; Shui AM; Cheng WY; Fan T; Hu W; Zichlin ML; Duh MS; Ye F; Levin PA
    Endocr Pract; 2018 Sep; 24(9):805-814. PubMed ID: 29975575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.
    Gerber BS; Rapacki L; Castillo A; Tilton J; Touchette DR; Mihailescu D; Berbaum ML; Sharp LK
    BMC Public Health; 2012 Oct; 12():891. PubMed ID: 23088168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of clinical pharmacy specialists and usual care in outpatient management of hyperglycemia in Veterans Affairs medical centers.
    Ourth HL; Hur K; Morreale AP; Cunningham F; Thakkar B; Aspinall S
    Am J Health Syst Pharm; 2019 Jan; 76(1):26-33. PubMed ID: 31381096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of patients with type 2 diabetes by pharmacists in primary care clinics.
    Coast-Senior EA; Kroner BA; Kelley CL; Trilli LE
    Ann Pharmacother; 1998 Jun; 32(6):636-41. PubMed ID: 9640480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
    Wallgren S; Berry-Cabán CS; Bowers L
    Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic inertia and intensified treatment in diabetes mellitus prescription patterns: A nationwide population-based study in Taiwan.
    Huang LY; Yeh HL; Yang MC; Shau WY; Su S; Lai MS
    J Int Med Res; 2016 Dec; 44(6):1263-1271. PubMed ID: 28322095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
    Tong L; Pan C; Wang H; Bertolini M; Lew E; Meneghini LF
    Diabetes Obes Metab; 2018 Apr; 20(4):831-839. PubMed ID: 29119712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.